RE:RE:Discussions Involve Multiple Partners in Varying FormatsI don't recall seeing any data tha differentiated SGLTs either so afaik none have been shown to work significantly better than others.
I've seen you mention $8/share before from Agoracom. I think that was just one poster's guess as to where we would be at in August. Nothing scientific or from a company source.
I think upfront payment will be >$100m as well, but trying not to get myself too excited. Someone on Agora a couple weeks ago listed some prior pharma partnership deals and the upfront payments were generally substantial. I can't find that post now though to share, unfortunately.